BIOLASE Inc Share Price Nasdaq
Equities
US0909111082
Advanced Medical Equipment & Technology
Sales 2024 * | 50.67M 3.99B | Sales 2025 * | 54.66M 4.3B | Capitalization | 5.37M 422M |
---|---|---|---|---|---|
Net income 2024 * | -10M -787M | Net income 2025 * | -6M -472M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-1.69
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.67% |
Latest transcript on BIOLASE Inc
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 30/09/17 |
Director of Finance/CFO | 53 | 31/01/21 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 31/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 31/07/14 |
John Beaver
CEO | Chief Executive Officer | 62 | 30/09/17 |
Director/Board Member | 73 | 15/08/21 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 227B | |
+15.46% | 197B | |
+18.58% | 141B | |
+30.36% | 110B | |
+0.65% | 64.15B | |
+17.74% | 53.72B | |
+5.82% | 51.75B | |
+11.23% | 45.2B | |
+5.73% | 37.37B |